We are live on ! Find out more
OCUL icon

Ocular Therapeutix
OCUL

73 hedge funds and large institutions have $96.5M invested in Ocular Therapeutix in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 19

13% more call options, than puts

Call options by funds: $1.18M | Put options by funds: $1.05M

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

1% more funds holding

Funds holding: 72 → 73 (+1)

0.21% more ownership

Funds ownership: 53.41% → 53.62% (+0.21%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

33% less capital invested

Capital invested by funds: $144M → $96.5M (-$47.1M)

Holders
73
Holders Change
+1
Holders Change %
+1.39%
% of All Funds
1.82%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
9
Increased
24
Reduced
19
Closed
8
Calls
$1.18M
Puts
$1.05M
Net Calls
+$132K
Net Calls Change
+$341K

Top Buyers

Rank Fund Capital Flow
1
CCI
Columbus Circle Investors
+$3.19M
2
CS
Credit Suisse
Switzerland
+$1.48M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$795K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$255K
5
SC
Sculptor Capital
New York
+$250K

Top Sellers

Rank Fund Capital Flow
1
JMPWA
JP Morgan Private Wealth Advisors
California
-$3.12M
2
Morgan Stanley
Morgan Stanley
New York
-$829K
3
Deutsche Bank
Deutsche Bank
Germany
-$662K
4
CI
Cowen Inc
New York
-$456K
5
RPAM
Rhenman & Partners Asset Management
Sweden
-$371K
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
26
Sculptor Capital
New York
$307K +$250K +38,900 +364%
NA
27
NewEdge Advisors
Louisiana
$268K -$19.3K -3,000 -6%
TA
28
Teachers Advisors
New York
$264K – – –
AllianceBernstein
29
AllianceBernstein
Tennessee
$258K – – –
Bank of Montreal
30
Bank of Montreal
Ontario, Canada
$247K +$102K +15,902 +66%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$245K +$255K +39,664 New
Neuberger Berman Group
32
Neuberger Berman Group
New York
$239K +$56.4K +8,765 +29%
Charles Schwab
33
Charles Schwab
California
$238K – – –
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$229K -$18.7K -2,900 -7%
Goldman Sachs
35
Goldman Sachs
New York
$227K +$21.5K +3,342 +10%
ARTA
36
A.R.T. Advisors
New York
$222K +$32.6K +5,059 +16%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$184K +$15.8K +2,449 +9%
AA
38
ALPS Advisors
Colorado
$177K +$15.4K +2,386 +9%
Capital Fund Management (CFM)
39
Capital Fund Management (CFM)
France
$167K +$174K +27,000 New
AQR Capital Management
40
AQR Capital Management
Connecticut
$131K +$137K +21,256 New
Deutsche Bank
41
Deutsche Bank
Germany
$122K -$662K -102,862 -84%
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$115K – – –
State of Wisconsin Investment Board
43
State of Wisconsin Investment Board
Wisconsin
$111K – – –
AIG
44
American International Group
New York
$93K +$7.28K +1,130 +8%
Creative Planning
45
Creative Planning
Kansas
$90K +$43.8K +6,800 +87%
Millennium Management
46
Millennium Management
New York
$80K +$83.8K +13,021 New
NFA
47
Nationwide Fund Advisors
Ohio
$76K – – –
State Board of Administration of Florida Retirement System
48
State Board of Administration of Florida Retirement System
Florida
$70K – – –
LCM
49
Landscape Capital Management
New Jersey
$70K +$72.7K +11,289 New
VOYA Investment Management
50
VOYA Investment Management
Georgia
$68K – – –
1
2
3 4

OCUL Hedge Fund Activity: Q3 2017 in Review

73 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Ocular Therapeutix (OCUL) for Q3 2017, worth a combined $96.5M — down 33% from $144M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new OCUL positions and 8 closed out — a net gain of 1 holder — while 24 added to existing stakes and 19 trimmed.

The largest buyer was Columbus Circle Investors, adding an estimated $3.19M. The largest seller was JP Morgan Private Wealth Advisors, exiting entirely with an estimated $3.12M sold.

  • 73 institutional investors held Ocular Therapeutix (OCUL) as of Q3 2017, up from 72 in Q2 2017.
  • Funds reported $96.5M of Ocular Therapeutix stock for Q3 2017, down 33% quarter-over-quarter.
  • 9 funds opened new Ocular Therapeutix positions in Q3 2017 and 8 closed out, a net change of +1 holder.
  • The largest Ocular Therapeutix buyer in Q3 2017 was Columbus Circle Investors, an estimated $3.19M added.
  • The largest Ocular Therapeutix seller in Q3 2017 was JP Morgan Private Wealth Advisors, an estimated $3.12M sold.

Based on aggregated 13F filings for Q3 2017.